Back to Search
Start Over
GSK's ViiV gets USD1.25 billion from Gilead patent pact
GSK's ViiV gets USD1.25 billion from Gilead patent pact
- Source :
- Plus Company Updates. February 3, 2022
- Publication Year :
- 2022
-
Abstract
- London: GlaxoSmithKline PLC has issued the following press release: GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent infringement litigation with Gilead Sciences [...]
- Subjects :
- Shionogi & Company Ltd. -- Intellectual property
Gilead Sciences Inc. -- Intellectual property
Pfizer Inc. -- Intellectual property
GlaxoSmithKline PLC -- Intellectual property
Biological products industry -- Intellectual property
Patent infringement
Pharmaceutical industry -- Intellectual property
General interest
News, opinion and commentary
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.692191897